Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Jan;29(1):155–157. doi: 10.1128/aac.29.1.155

Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.

C A Benson, F E Walton, G M Trenholme
PMCID: PMC180383  PMID: 3079583

Abstract

The in vitro activity of Ro 17-2301 was determined and compared with those of aztreonam, ceftazidime, amikacin, and piperacillin against 141 cefotaxime-resistant gram-negative bacilli. Ro 17-2301 was bactericidal, and its activity against the majority of these organisms was equal or superior to those of ceftazidime, aztreonam, and piperacillin. An inoculum effect of Ro 17-2301 and aztreonam for many Pseudomonas aeruginosa and Enterobacter spp. isolates was demonstrated.

Full text

PDF
155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eng R. H., Smith S. M., Cherubin C. Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Jul;26(1):42–47. doi: 10.1128/aac.26.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. McNulty C. A., Garden G. M., Ashby J., Wise R. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam. Antimicrob Agents Chemother. 1985 Sep;28(3):425–427. doi: 10.1128/aac.28.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ng W. W., Chau P. Y., Leung Y. K., Livermore D. M. In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1985 May;27(5):872–873. doi: 10.1128/aac.27.5.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Phillips I., King A., Shannon K., Warren C. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):103–110. doi: 10.1093/jac/8.suppl_e.103. [DOI] [PubMed] [Google Scholar]
  5. Sykes R. B., Bonner D. P., Bush K., Georgopapadakou N. H. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother. 1982 Jan;21(1):85–92. doi: 10.1128/aac.21.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sykes R. B., Bonner D. P., Bush K., Georgopapadakou N. H., Wells J. S. Monobactams--monocyclic beta-lactam antibiotics produced by bacteria. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):1–16. doi: 10.1093/jac/8.suppl_e.1. [DOI] [PubMed] [Google Scholar]
  7. Wise R., Andrews J. M., Hancox J. SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):39–47. doi: 10.1093/jac/8.suppl_e.39. [DOI] [PubMed] [Google Scholar]
  8. Wise R., Andrews J. M., Piddock L. J. The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents. J Antimicrob Chemother. 1985 Feb;15(2):193–200. doi: 10.1093/jac/15.2.193. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES